Hainan TV: first successful gene editing treatment of thalassemia in Hainan
Hainan Television reported the first successful gene editing treatment of thalassemia in Hainan, highlighting Reforgene's innovation.
China Association of Social Workers launches public assistance program for thalassemia
A public assistance program for thalassemia was officially launched by the China Association of Social Workers.
Guangzhou TV: innovative medicine renews hope as Reforgene's gene editing drug achieves clinical cure in a girl with severe thalassemia
Guangzhou Television reported that Reforgene's gene editing drug achieved clinical cure in a girl with severe thalassemia.
Repairing genes with an approved 'gene scissors': a girl with severe thalassemia achieves clinical cure
Using an approved gene editing approach, a girl with severe thalassemia achieved clinical cure.
AI plus gene editing: how this company successfully treated adult thalassemia
A media feature on how Reforgene combines AI and gene editing and has successfully treated adult thalassemia.
Breakthrough: China's gene editing technology successfully treats adult severe thalassemia
Media reports highlight a breakthrough in which China's gene editing technology successfully treated adult patients with severe thalassemia.
Reforgene achieves a new breakthrough in treating severe beta-thalassemia with a novel global target
Reforgene reported a new breakthrough in treating severe beta-thalassemia through a novel global target.
NMPA CDE issues guidance on common formats for manufacturing processes and quality standards of Chinese medicines, chemicals and biological products
China's CDE issued guidance on common formats for manufacturing processes and quality standards across drug categories.